Management of Rapid Atrial Fibrillation Post-Opioid Overdose
Immediate Assessment and Stabilization
- The American Heart Association recommends opening the airway and providing rescue breathing or bag-mask ventilation immediately if respiratory depression is present, and administering naloxone (0.4-2 mg IV/IM/intranasal) for patients with definite pulse but absent or inadequate breathing 3, 4, 5
- The American College of Cardiology states that airway and breathing take absolute priority over arrhythmia management in opioid overdose 3, 4, 5
Management of Hemodynamically Unstable Rapid AFib
- The American College of Cardiology recommends performing immediate R-wave synchronized direct-current cardioversion if the patient exhibits symptomatic hypotension, ongoing myocardial ischemia, angina, or heart failure that does not respond promptly to pharmacological measures, with a Class I recommendation and Level of Evidence C 1, 2
- The American College of Cardiology advises against delaying cardioversion to achieve anticoagulation in hemodynamically unstable patients, and recommends administering heparin concurrently (unless contraindicated) with initial IV bolus followed by continuous infusion to maintain aPTT 1.5-2 times control 1, 2, 6
Management of Hemodynamically Stable Rapid AFib
- The American College of Cardiology suggests initiating rate control with intravenous beta-blockers as first-line therapy for stable patients, with metoprolol and esmolol as options 7, 8
- The American College of Cardiology recommends exercising caution with beta-blockers if overt pulmonary congestion, hypotension, or reduced left ventricular ejection fraction is present 7
Post-Stabilization Management
- The American Heart Association recommends observing patients in a healthcare setting until risk of recurrent opioid toxicity is low and vital signs have normalized, and monitoring for recurrent respiratory depression 3
- The American College of Cardiology advises considering naloxone infusion or repeated doses if recurrent toxicity develops, and anticoagulation for at least 4 weeks post-cardioversion (INR 2.0-3.0) regardless of method used 1, 2, 3